Robert Hauser, MD, Neurology, Tampa, FL

RobertHauserMD

Neurology Tampa, FL

Movement Disorder

Professor of Neurology, University S Fla College of Medicine

Dr. Hauser is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hauser's full profile

Already have an account?

  • Office

    4001 E Fletcher Ave, 6th Fl
    Parkinson's Disease/Movement Disorders Ctr
    Tampa, FL 33613
    Phone(813) 396-0751
    Fax(813) 905-9829
  • Is this information wrong?

Summary

  • Dr. Robert Hauser is Director of the Parkinson's Disease and Movement Disorders Center of the University of South Florida. He received his medical degree from Temple University School of Medicine and has been in practice 31 years. He specializes in Parkinson's disease and is an expert in clinical research to develop new treatments for Parkinson's disease and related disorders. He also performs Botox injections for cervical dystonia, blepharospasm, and hemifacial spasm. He has published over 300 peer reviewed articles and lectures frequently at scientific meetings.

Education & Training

  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolResidency, Neurology, 1983 - 1988
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkInternship, Transitional Year, 1982 - 1983
  • Temple University School of Medicine
    Temple University School of MedicineClass of 1982

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1989 - 2022
  • PA State Medical License
    PA State Medical License 1988 - 1990
  • CA State Medical License
    CA State Medical License 1986 - 1992
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Therapeutic Strategies for Parkinson Disease: Beyond Dopaminergic Drugs  
    Robert Hauser, MD, Nature

Press Mentions

  • Acorda Therapeutics Announces FDA Approval of INBRIJA™ (Levodopa Inhalation Powder)
    Acorda Therapeutics Announces FDA Approval of INBRIJA™ (Levodopa Inhalation Powder)February 12th, 2020
  • Enterin's RASMET Study Published
    Enterin's RASMET Study PublishedAugust 27th, 2019
  • Seelos Therapeutics Acquires Rights for Parkinson’s Gene Therapy Program
    Seelos Therapeutics Acquires Rights for Parkinson’s Gene Therapy ProgramJuly 8th, 2019
  • Join now to see all

Professional Memberships